APO Research
Talk to an analyst

APO RESEARCH · REPORT

Histone Deacetylase 2

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Histone Deacetylase 2 Market Outlook and Growth Opportunities 2026

19 December 2025197 pages

Choose your research edition.

Industry ResearchHistone Deacetylase 2 Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Histone Deacetylase 2 Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Histone Deacetylase 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Histone Deacetylase 2 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Histone Deacetylase 2 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Histone Deacetylase 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Histone Deacetylase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Histone Deacetylase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Histone Deacetylase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Histone Deacetylase 2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Histone Deacetylase 2 market include 4SC AG, Merck & Co., Inc., GlaxoSmithKline Plc, Yungjin Pharm. Co., Ltd., TetraLogic Pharmaceuticals, Sigma-Tau S.p.A., Rodin Therapeutics, MEI Pharma, Inc. and Italfarmaco S.p.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Histone Deacetylase 2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Histone Deacetylase 2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Histone Deacetylase 2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Histone Deacetylase 2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Histone Deacetylase 2 Segment by Company

4SC AG

Merck & Co., Inc.

GlaxoSmithKline Plc

Yungjin Pharm. Co., Ltd.

TetraLogic Pharmaceuticals

Sigma-Tau S.p.A.

Rodin Therapeutics

MEI Pharma, Inc.

Italfarmaco S.p.A.

HitGen LTD

Curis, Inc.

Chipscreen Biosciences Ltd

Acetylon Pharmaceuticals, Inc.

Histone Deacetylase 2 Segment by Type

ACY-957

CS-3158

HG-3001

RCY-1305

Others

Histone Deacetylase 2 Segment by Application

Bladder Cancer

Non-Hodgkin Lymphoma

Colon Cancer

Alopecia

Others

Histone Deacetylase 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Histone Deacetylase 2 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Histone Deacetylase 2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Histone Deacetylase 2 significant trends, drivers, influence factors in global and regions.

6. To analyze Histone Deacetylase 2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Deacetylase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Histone Deacetylase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Deacetylase 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Histone Deacetylase 2 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Histone Deacetylase 2 industry.

Chapter 3: Detailed analysis of Histone Deacetylase 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Histone Deacetylase 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Histone Deacetylase 2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Histone Deacetylase 2 Industry Trends Table 2. Histone Deacetylase 2 Industry Drivers Table 3. Histone Deacetylase 2 Industry Opportunities and Challenges Table 4. Histone Deacetylase 2 Industry Restraints Table 5. Global Histone Deacetylase 2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Histone Deacetylase 2 Revenue Share by Company (2021-2026) Table 7. Global Histone Deacetylase 2 Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Histone Deacetylase 2 Sales Volume Share by Company (2021-2026) Table 9. Global Histone Deacetylase 2 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Histone Deacetylase 2 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Histone Deacetylase 2 Key Company Manufacturing Base & Headquarters Table 12. Global Histone Deacetylase 2 Company, Product Type & Application Table 13. Global Histone Deacetylase 2 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Histone Deacetylase 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of ACY-957 Table 18. Significant Companies of CS-3158 Table 19. Significant Companies of HG-3001 Table 20. Significant Companies of RCY-1305 Table 21. Significant Companies of Others Table 22. Global Histone Deacetylase 2 Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Histone Deacetylase 2 Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Histone Deacetylase 2 Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Histone Deacetylase 2 Sales Volume Share by Type (2021-2026) Table 26. Global Histone Deacetylase 2 Sales Volume Share by Type (2027-2032) Table 27. Global Histone Deacetylase 2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Histone Deacetylase 2 Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Histone Deacetylase 2 Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Histone Deacetylase 2 Sales Value Share by Type (2021-2026) Table 31. Global Histone Deacetylase 2 Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Bladder Cancer Table 33. Significant Companies of Non-Hodgkin Lymphoma Table 34. Significant Companies of Colon Cancer Table 35. Significant Companies of Alopecia Table 36. Significant Companies of Others Table 37. Global Histone Deacetylase 2 Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Histone Deacetylase 2 Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Histone Deacetylase 2 Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Histone Deacetylase 2 Sales Volume Share by Application (2021-2026) Table 41. Global Histone Deacetylase 2 Sales Volume Share by Application (2027-2032) Table 42. Global Histone Deacetylase 2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Histone Deacetylase 2 Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Histone Deacetylase 2 Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Histone Deacetylase 2 Sales Value Share by Application (2021-2026) Table 46. Global Histone Deacetylase 2 Sales Value Share by Application (2027-2032) Table 47. Global Histone Deacetylase 2 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Histone Deacetylase 2 Sales by Region (2021-2026) & (K Units) Table 49. Global Histone Deacetylase 2 Sales Market Share by Region (2021-2026) Table 50. Global Histone Deacetylase 2 Sales by Region (2027-2032) & (K Units) Table 51. Global Histone Deacetylase 2 Sales Market Share by Region (2027-2032) Table 52. Global Histone Deacetylase 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Histone Deacetylase 2 Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Histone Deacetylase 2 Sales Value Share by Region (2021-2026) Table 55. Global Histone Deacetylase 2 Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Histone Deacetylase 2 Sales Value Share by Region (2027-2032) Table 57. Global Histone Deacetylase 2 Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Histone Deacetylase 2 Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Histone Deacetylase 2 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Histone Deacetylase 2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Histone Deacetylase 2 Sales by Country (2021-2026) & (K Units) Table 62. Global Histone Deacetylase 2 Sales Market Share by Country (2021-2026) Table 63. Global Histone Deacetylase 2 Sales by Country (2027-2032) & (K Units) Table 64. Global Histone Deacetylase 2 Sales Market Share by Country (2027-2032) Table 65. Global Histone Deacetylase 2 Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Histone Deacetylase 2 Sales Value Market Share by Country (2021-2026) Table 67. Global Histone Deacetylase 2 Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Histone Deacetylase 2 Sales Value Market Share by Country (2027-2032) Table 69. 4SC AG Company Information Table 70. 4SC AG Business Overview Table 71. 4SC AG Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. 4SC AG Histone Deacetylase 2 Product Portfolio Table 73. 4SC AG Recent Development Table 74. Merck & Co., Inc. Company Information Table 75. Merck & Co., Inc. Business Overview Table 76. Merck & Co., Inc. Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Merck & Co., Inc. Histone Deacetylase 2 Product Portfolio Table 78. Merck & Co., Inc. Recent Development Table 79. GlaxoSmithKline Plc Company Information Table 80. GlaxoSmithKline Plc Business Overview Table 81. GlaxoSmithKline Plc Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline Plc Histone Deacetylase 2 Product Portfolio Table 83. GlaxoSmithKline Plc Recent Development Table 84. Yungjin Pharm. Co., Ltd. Company Information Table 85. Yungjin Pharm. Co., Ltd. Business Overview Table 86. Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Product Portfolio Table 88. Yungjin Pharm. Co., Ltd. Recent Development Table 89. TetraLogic Pharmaceuticals Company Information Table 90. TetraLogic Pharmaceuticals Business Overview Table 91. TetraLogic Pharmaceuticals Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. TetraLogic Pharmaceuticals Histone Deacetylase 2 Product Portfolio Table 93. TetraLogic Pharmaceuticals Recent Development Table 94. Sigma-Tau S.p.A. Company Information Table 95. Sigma-Tau S.p.A. Business Overview Table 96. Sigma-Tau S.p.A. Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sigma-Tau S.p.A. Histone Deacetylase 2 Product Portfolio Table 98. Sigma-Tau S.p.A. Recent Development Table 99. Rodin Therapeutics Company Information Table 100. Rodin Therapeutics Business Overview Table 101. Rodin Therapeutics Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Rodin Therapeutics Histone Deacetylase 2 Product Portfolio Table 103. Rodin Therapeutics Recent Development Table 104. MEI Pharma, Inc. Company Information Table 105. MEI Pharma, Inc. Business Overview Table 106. MEI Pharma, Inc. Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. MEI Pharma, Inc. Histone Deacetylase 2 Product Portfolio Table 108. MEI Pharma, Inc. Recent Development Table 109. Italfarmaco S.p.A. Company Information Table 110. Italfarmaco S.p.A. Business Overview Table 111. Italfarmaco S.p.A. Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Italfarmaco S.p.A. Histone Deacetylase 2 Product Portfolio Table 113. Italfarmaco S.p.A. Recent Development Table 114. HitGen LTD Company Information Table 115. HitGen LTD Business Overview Table 116. HitGen LTD Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. HitGen LTD Histone Deacetylase 2 Product Portfolio Table 118. HitGen LTD Recent Development Table 119. Curis, Inc. Company Information Table 120. Curis, Inc. Business Overview Table 121. Curis, Inc. Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Curis, Inc. Histone Deacetylase 2 Product Portfolio Table 123. Curis, Inc. Recent Development Table 124. Chipscreen Biosciences Ltd Company Information Table 125. Chipscreen Biosciences Ltd Business Overview Table 126. Chipscreen Biosciences Ltd Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Chipscreen Biosciences Ltd Histone Deacetylase 2 Product Portfolio Table 128. Chipscreen Biosciences Ltd Recent Development Table 129. Acetylon Pharmaceuticals, Inc. Company Information Table 130. Acetylon Pharmaceuticals, Inc. Business Overview Table 131. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Product Portfolio Table 133. Acetylon Pharmaceuticals, Inc. Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Histone Deacetylase 2 Distributors List Table 137. Histone Deacetylase 2 Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Histone Deacetylase 2 Product Image Figure 2. Global Histone Deacetylase 2 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Histone Deacetylase 2 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Histone Deacetylase 2 Sales (2021-2032) & (K Units) Figure 5. Global Histone Deacetylase 2 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Histone Deacetylase 2 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. ACY-957 Image Figure 10. CS-3158 Image Figure 11. HG-3001 Image Figure 12. RCY-1305 Image Figure 13. Others Image Figure 14. Global Histone Deacetylase 2 Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Histone Deacetylase 2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Histone Deacetylase 2 Sales Volume Share by Type (2021-2032) Figure 17. Global Histone Deacetylase 2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Histone Deacetylase 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Histone Deacetylase 2 Sales Value Share by Type (2021-2032) Figure 20. Bladder Cancer Image Figure 21. Non-Hodgkin Lymphoma Image Figure 22. Colon Cancer Image Figure 23. Alopecia Image Figure 24. Others Image Figure 25. Global Histone Deacetylase 2 Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Histone Deacetylase 2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Histone Deacetylase 2 Sales Volume Share by Application (2021-2032) Figure 28. Global Histone Deacetylase 2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Histone Deacetylase 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Histone Deacetylase 2 Sales Value Share by Application (2021-2032) Figure 31. Global Histone Deacetylase 2 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Histone Deacetylase 2 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Histone Deacetylase 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Histone Deacetylase 2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Histone Deacetylase 2 Sales Value (2021-2032) & (US$ Million) Figure 36. North America Histone Deacetylase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Histone Deacetylase 2 Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Histone Deacetylase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Histone Deacetylase 2 Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Histone Deacetylase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Histone Deacetylase 2 Sales Value (2021-2032) & (US$ Million) Figure 42. South America Histone Deacetylase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Histone Deacetylase 2 Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Histone Deacetylase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Histone Deacetylase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Histone Deacetylase 2 Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Histone Deacetylase 2 Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • ACY-957
  • CS-3158
  • HG-3001
  • RCY-1305
  • Others
Applications
  • Bladder Cancer
  • Non-Hodgkin Lymphoma
  • Colon Cancer
  • Alopecia
  • Others
Companies covered
  • 4SC AG
  • Merck & Co., Inc.
  • GlaxoSmithKline Plc
  • Yungjin Pharm. Co., Ltd.
  • TetraLogic Pharmaceuticals
  • Sigma-Tau S.p.A.
  • Rodin Therapeutics
  • MEI Pharma, Inc.
  • Italfarmaco S.p.A.
  • HitGen LTD
  • Curis, Inc.
  • Chipscreen Biosciences Ltd
  • Acetylon Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Histone Deacetylase 2 Sales Value (2021-2032)
  4. 1.2.2 Global Histone Deacetylase 2 Sales Volume (2021-2032)
  5. 1.2.3 Global Histone Deacetylase 2 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Histone Deacetylase 2 Market Dynamics
  1. 2.1 Histone Deacetylase 2 Industry Trends
  2. 2.2 Histone Deacetylase 2 Industry Drivers
  3. 2.3 Histone Deacetylase 2 Industry Opportunities and Challenges
  4. 2.4 Histone Deacetylase 2 Industry Restraints
3 Histone Deacetylase 2 Market by Company
  1. 3.1 Global Histone Deacetylase 2 Company Revenue Ranking in 2025
  2. 3.2 Global Histone Deacetylase 2 Revenue by Company (2021-2026)
  3. 3.3 Global Histone Deacetylase 2 Sales Volume by Company (2021-2026)
  4. 3.4 Global Histone Deacetylase 2 Average Price by Company (2021-2026)
  5. 3.5 Global Histone Deacetylase 2 Company Ranking (2024-2026)
  6. 3.6 Global Histone Deacetylase 2 Company Manufacturing Base and Headquarters
  7. 3.7 Global Histone Deacetylase 2 Company Product Type and Application
  8. 3.8 Global Histone Deacetylase 2 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Histone Deacetylase 2 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Histone Deacetylase 2 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Histone Deacetylase 2 Market by Type
  1. 4.1 Histone Deacetylase 2 Type Introduction
  2. 4.1.1 ACY-957
  3. 4.1.2 CS-3158
  4. 4.1.3 HG-3001
  5. 4.1.4 RCY-1305
  6. 4.1.5 Others
  7. 4.2 Global Histone Deacetylase 2 Sales Volume by Type
  8. 4.2.1 Global Histone Deacetylase 2 Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Histone Deacetylase 2 Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Histone Deacetylase 2 Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Histone Deacetylase 2 Sales Value by Type
  12. 4.3.1 Global Histone Deacetylase 2 Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Histone Deacetylase 2 Sales Value by Type (2021-2032)
  14. 4.3.3 Global Histone Deacetylase 2 Sales Value Share by Type (2021-2032)
5 Histone Deacetylase 2 Market by Application
  1. 5.1 Histone Deacetylase 2 Application Introduction
  2. 5.1.1 Bladder Cancer
  3. 5.1.2 Non-Hodgkin Lymphoma
  4. 5.1.3 Colon Cancer
  5. 5.1.4 Alopecia
  6. 5.1.5 Others
  7. 5.2 Global Histone Deacetylase 2 Sales Volume by Application
  8. 5.2.1 Global Histone Deacetylase 2 Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Histone Deacetylase 2 Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Histone Deacetylase 2 Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Histone Deacetylase 2 Sales Value by Application
  12. 5.3.1 Global Histone Deacetylase 2 Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Histone Deacetylase 2 Sales Value by Application (2021-2032)
  14. 5.3.3 Global Histone Deacetylase 2 Sales Value Share by Application (2021-2032)
6 Histone Deacetylase 2 Regional Sales and Value Analysis
  1. 6.1 Global Histone Deacetylase 2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Histone Deacetylase 2 Sales by Region (2021-2032)
  3. 6.2.1 Global Histone Deacetylase 2 Sales by Region: 2021-2026
  4. 6.2.2 Global Histone Deacetylase 2 Sales by Region (2027-2032)
  5. 6.3 Global Histone Deacetylase 2 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Histone Deacetylase 2 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Histone Deacetylase 2 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Histone Deacetylase 2 Sales Value by Region (2027-2032)
  9. 6.5 Global Histone Deacetylase 2 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Histone Deacetylase 2 Sales Value (2021-2032)
  12. 6.6.2 North America Histone Deacetylase 2 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Histone Deacetylase 2 Sales Value (2021-2032)
  15. 6.7.2 Europe Histone Deacetylase 2 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Histone Deacetylase 2 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Histone Deacetylase 2 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Histone Deacetylase 2 Sales Value (2021-2032)
  21. 6.9.2 South America Histone Deacetylase 2 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Histone Deacetylase 2 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Histone Deacetylase 2 Sales Value Share by Country, 2025 VS 2032
7 Histone Deacetylase 2 Country-level Sales and Value Analysis
  1. 7.1 Global Histone Deacetylase 2 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Histone Deacetylase 2 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Histone Deacetylase 2 Sales by Country (2021-2032)
  4. 7.3.1 Global Histone Deacetylase 2 Sales by Country (2021-2026)
  5. 7.3.2 Global Histone Deacetylase 2 Sales by Country (2027-2032)
  6. 7.4 Global Histone Deacetylase 2 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Histone Deacetylase 2 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Histone Deacetylase 2 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Histone Deacetylase 2 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Histone Deacetylase 2 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Histone Deacetylase 2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 4SC AG
  2. 8.1.1 4SC AG Company Information
  3. 8.1.2 4SC AG Business Overview
  4. 8.1.3 4SC AG Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 4SC AG Histone Deacetylase 2 Product Portfolio
  6. 8.1.5 4SC AG Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Histone Deacetylase 2 Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 GlaxoSmithKline Plc
  14. 8.3.1 GlaxoSmithKline Plc Company Information
  15. 8.3.2 GlaxoSmithKline Plc Business Overview
  16. 8.3.3 GlaxoSmithKline Plc Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Plc Histone Deacetylase 2 Product Portfolio
  18. 8.3.5 GlaxoSmithKline Plc Recent Developments
  19. 8.4 Yungjin Pharm. Co., Ltd.
  20. 8.4.1 Yungjin Pharm. Co., Ltd. Company Information
  21. 8.4.2 Yungjin Pharm. Co., Ltd. Business Overview
  22. 8.4.3 Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Product Portfolio
  24. 8.4.5 Yungjin Pharm. Co., Ltd. Recent Developments
  25. 8.5 TetraLogic Pharmaceuticals
  26. 8.5.1 TetraLogic Pharmaceuticals Company Information
  27. 8.5.2 TetraLogic Pharmaceuticals Business Overview
  28. 8.5.3 TetraLogic Pharmaceuticals Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 TetraLogic Pharmaceuticals Histone Deacetylase 2 Product Portfolio
  30. 8.5.5 TetraLogic Pharmaceuticals Recent Developments
  31. 8.6 Sigma-Tau S.p.A.
  32. 8.6.1 Sigma-Tau S.p.A. Company Information
  33. 8.6.2 Sigma-Tau S.p.A. Business Overview
  34. 8.6.3 Sigma-Tau S.p.A. Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sigma-Tau S.p.A. Histone Deacetylase 2 Product Portfolio
  36. 8.6.5 Sigma-Tau S.p.A. Recent Developments
  37. 8.7 Rodin Therapeutics
  38. 8.7.1 Rodin Therapeutics Company Information
  39. 8.7.2 Rodin Therapeutics Business Overview
  40. 8.7.3 Rodin Therapeutics Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Rodin Therapeutics Histone Deacetylase 2 Product Portfolio
  42. 8.7.5 Rodin Therapeutics Recent Developments
  43. 8.8 MEI Pharma, Inc.
  44. 8.8.1 MEI Pharma, Inc. Company Information
  45. 8.8.2 MEI Pharma, Inc. Business Overview
  46. 8.8.3 MEI Pharma, Inc. Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MEI Pharma, Inc. Histone Deacetylase 2 Product Portfolio
  48. 8.8.5 MEI Pharma, Inc. Recent Developments
  49. 8.9 Italfarmaco S.p.A.
  50. 8.9.1 Italfarmaco S.p.A. Company Information
  51. 8.9.2 Italfarmaco S.p.A. Business Overview
  52. 8.9.3 Italfarmaco S.p.A. Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Italfarmaco S.p.A. Histone Deacetylase 2 Product Portfolio
  54. 8.9.5 Italfarmaco S.p.A. Recent Developments
  55. 8.10 HitGen LTD
  56. 8.10.1 HitGen LTD Company Information
  57. 8.10.2 HitGen LTD Business Overview
  58. 8.10.3 HitGen LTD Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 HitGen LTD Histone Deacetylase 2 Product Portfolio
  60. 8.10.5 HitGen LTD Recent Developments
  61. 8.11 Curis, Inc.
  62. 8.11.1 Curis, Inc. Company Information
  63. 8.11.2 Curis, Inc. Business Overview
  64. 8.11.3 Curis, Inc. Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Curis, Inc. Histone Deacetylase 2 Product Portfolio
  66. 8.11.5 Curis, Inc. Recent Developments
  67. 8.12 Chipscreen Biosciences Ltd
  68. 8.12.1 Chipscreen Biosciences Ltd Company Information
  69. 8.12.2 Chipscreen Biosciences Ltd Business Overview
  70. 8.12.3 Chipscreen Biosciences Ltd Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Chipscreen Biosciences Ltd Histone Deacetylase 2 Product Portfolio
  72. 8.12.5 Chipscreen Biosciences Ltd Recent Developments
  73. 8.13 Acetylon Pharmaceuticals, Inc.
  74. 8.13.1 Acetylon Pharmaceuticals, Inc. Company Information
  75. 8.13.2 Acetylon Pharmaceuticals, Inc. Business Overview
  76. 8.13.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Product Portfolio
  78. 8.13.5 Acetylon Pharmaceuticals, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Histone Deacetylase 2 Value Chain Analysis
  2. 9.1.1 Histone Deacetylase 2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Histone Deacetylase 2 Sales Mode & Process
  6. 9.2 Histone Deacetylase 2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Histone Deacetylase 2 Distributors
  9. 9.2.3 Histone Deacetylase 2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst